Farbod Tabesh

Dr. Farbod Tabesh

Radiology, Stanford University School of Medicine, Stanford, California, USA
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2025
Verified
Journal Article
Open access
HSHassan Sepehrmansourie
Hassan Sepehrmansourie
MZMahmoud Zarei
Mahmoud Zarei
SMShadpour Mallakpour
Shadpour Mallakpour
FTFarbod Tabesh
Farbod Tabesh
Mohammad Ali ZolfigolMohammad Ali Zolfigol
Mohammad Ali Zolfigol
Ipso reaction is a class of nitration reactions that involve the concerted movement of multiple atoms in a transition state. Nitro structures are vital intermediates in synthetic organic chemistry and related industries. This method has been introduced in the preparation of NO2-containing structures with a wide range of leaving groups such as –B(OH)2, –CO2H, –SO3H, –OR, –R, –X, –CHO, –COMe, –CO2Me, –MR3 and –BF3K. Ipso nitration reactions have an essential impact on the synthesis of complex organic molecules and have been widely studied and utilized in organic chemistry. This review provides a comprehensive overview of the fundamental concepts and mechanisms underlying ipso reactions, highlighting their significance in contemporary organic chemistry.

Verified
Journal Article
Open access
PDF file
RBRakesh Bam
Rakesh Bam
ANArutselvan Natarajan
Arutselvan Natarajan
FTFarbod Tabesh
Farbod Tabesh
RPRamasamy Paulmurugan
Ramasamy Paulmurugan
JDJeremy Dahl
Jeremy Dahl
The main aim of this study is to synthesize contrast microbubbles (MB) functionalized with engineered protein ligands using a microfluidic device to target breast cancer specific vascular B7-H3 receptor in vivo for diagnostic ultrasound imaging. We used a high-affinity affibody (ABY) selected against human/mouse B7-H3 receptor for engineering targeted MBs (TMBs). We introduced a C-terminal cysteine residue to this ABY ligand for facilitating site-specific conjugation to DSPE-PEG-2K-maleimide (M. Wt = 2.9416 kDa) phospholipid for MB formulation. We optimized the reaction conditions of bioconjugations and applied it for microfluidic based synthesis of TMBs using DSPE-PEG-ABY and DPPC liposomes (5:95 mole %). The binding affinity of TMBs to B7-H3 (MBB7-H3) was tested in vitro in MS1 endothelial cells expressing human B7-H3 (MS1B7-H3) by flow chamber assay, and by ex vivo in the mammary tumors of a transgenic mouse model (FVB/N-Tg (MMTV-PyMT)634Mul/J), expressing murine B7-H3 in the vascular endothelial cells by immunostaining analyses. We successfully optimized the conditions needed for generating TMBs using a microfluidic system. The synthesized MBs showed higher affinity to MS1 cells engineered to express higher level of hB7-H3, and in the endothelial cells of mouse tumor tissue upon injecting TMBs in a live animal. The average number (mean ± SD) of MBB7-H3 binding to MS1B7-H3 cells was estimated to be 354.4 ± 52.3 per field of view (FOV) compared to wild-type control cells (MS1WT; 36.2 ± 7.5/FOV). The non-targeted MBs did not show any selective binding affinity to both the cells (37.7 ± 7.8/FOV for MS1B7-H3 and 28.3 ± 6.7/FOV for MS1WT cells). The fluorescently labeled MBB7-H3 upon systemic injection in vivo co-localized to tumor vessels, expressing B7-H3 receptor, as validated by ex vivo immunofluorescence analyses. We have successfully synthesized a novel MBB7-H3 via microfluidic device, which allows us to produce on demand TMBs for clinical applications. This clinically translatable MBB7-H3 showed significant binding affinity to vascular endothelial cells expressing B7-H3 both in vitro and in vivo, which shows its potential for clinical translation as a molecular ultrasound contrast agent for human applications.


23 December 2025 in IEEE Transactions on Ultrasonics
Verified
Journal Article
Closed access
HHHoda S. Hashemi
Hoda S. Hashemi
DHDongwoon Hyun
Dongwoon Hyun
NNNathan Nguyen
Nathan Nguyen
JBJihye Baek
Jihye Baek
ANArutselvan Natarajan
Arutselvan Natarajan
JDJeremy Dahl
Jeremy Dahl
Ultrasound molecular imaging (UMI) is an advanced imaging modality that shows promise in detecting cancer at early stages. It uses microbubbles as contrast agents, which are functionalized to bind to cancer biomarkers overexpressed on endothelial cells. A major challenge in UMI is isolating bound microbubble signal, which represents the molecular imaging signal, from that of free-floating microbubbles, which is considered background noise. In this work, we propose a fast GPU-based method using robust principal component analysis (RPCA) to distinguish bound microbubbles from free-floating ones. We explore the method using simulations and measure the accuracy using the Dice coefficient and RMS error as functions of the number of frames used in RPCA reconstruction. Experiments using stationary and flowing microbubbles in tissue-mimicking phantoms were used to validate the method. Additionally, the method was applied to data from ten transgenic mouse models of breast cancer development, injected with B7-H3 targeted microbubbles, and two mice injected with non-targeted microbubbles. The results showed that RPCA using 20 frames achieved a Dice score of 0.95 and a computation time of 0.2 seconds, indicating that 20 frames is potentially suitable for real-time implementation. On in vivo data, RPCA using 20 frames achieved a Dice score of 0.82 when compared with a conventional preclinical method, Differential Targeted Enhancement (DTE), indicating good agreement between the two, given the limitations of each method.

27 April 2026 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
JBJihye Baek
Jihye Baek
DHDongwoon Hyun
Dongwoon Hyun
ANArutselvan Natarajan
Arutselvan Natarajan
FTFarbod Tabesh
Farbod Tabesh
RPRamasamy Paulmurugan
Ramasamy Paulmurugan
JDJeremy Dahl
Jeremy Dahl
Ultrasound molecular imaging (USMI) is an imaging approach that utilizes targeted microbubbles (MBs) to highlight biomarkers of disease. While differential targeted enhancement (DTE) is the current state-of-the-art for USMI, its reliance on destructive pulses hinders real-time clinical application. We have developed a neural network-based nondestructive USMI, validated in vivo using a transgenic mouse model of spontaneous breast cancer. To enhance training efficacy despite a limited animal number (N=14), we utilized several augmentation strategies including the use of several targeted MB types for each animal to generate independent image and texture patterns, alternative DTE approaches (sham and injection DTE), and random patch selection, overall resulting in a total of 15,350 patches to train the network. The resulting nondestructive USMI produces an image of the pixelwise MB classification score of the presence of targeted MBs. Our nondestructive USMI achieved a correlation coefficient of 0.954 with DTE, a continuous dice coefficient of 0.863 for a molecular signal coverage of the lesion over 20%, and a higher AUC than DTE ( 0.954 vs. 0.845 ) compared to the reference image developed from the contrast enhanced ultrasound (CEUS) image and manual lesion contour. Nondestructive imaging during continuous motion of the transducer under elevation sweeps yielded fewer artifacts and higher AUC than DTE ( 0.953 vs. 0.892 ), compared to the reference image. This demonstrates the potential of free-hand and real-time nonde-structive imaging. Overall, nondestructive imaging showed comparable performance to DTE under stationary conditions and superior performance to DTE under transducer motion, indicating its clinical imaging potential.